FDA advisory committee

Image of a neon sign with the word no lit up next to an unlit yes
Pharma

FDA shoots down Intercept's bid for full approval of Ocaliva

In the wake of an unfavorable advisory committee meeting, Intercept's bid to win full approval for its liver disease drug Ocaliva has come up short.
Fraiser Kansteiner Nov 12, 2024 2:12pm
FDA

Experts back FDA's plan to restrict PD-1 drugs in GI cancers

Sep 26, 2024 1:38pm
FDA

FDA challenges broad use of PD-1 drugs in stomach cancer

Sep 24, 2024 2:30pm
liver doctor liver disease

Intercept's Ocaliva nod in danger after negative FDA adcomm vote

Sep 16, 2024 10:40am
liver

Ocaliva's fate looks bleak after FDA releases new briefing docs

Sep 11, 2024 4:58pm
FDA

With ODAC, FDA weighs limiting PD-1 drugs in stomach cancer

Aug 22, 2024 3:28pm